Business

Zeliras diabetic nerve pain drug outperforms Lyrica

Zeliras diabetic nerve pain drug outperforms Lyrica

Zelira Therapeutics Ltd.May 31, 20234
Zeliras diabetic nerve pain drug outperforms Lyrica

About this update from Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Zelira Therapeutics Ltd.

More from Zelira Therapeutics Ltd.

All Zelira Therapeutics Ltd. news →